Cite
The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma
MLA
Laura Paris, et al. The Timing of Plerixafor Addition to G-Csf and Chemotherapy Affects Immunological Recovery after Autologous Stem Cell Transplant in Multiple Myeloma. Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b68588ab0c0ceae1e07821073e978145&authtype=sso&custid=ns315887.
APA
Laura Paris, Francesca Patriarca, Renato Fanin, Monica Galli, Elisa Dan, Andrea Olmo, Beatrice Anna Zannetti, Michele Cavo, Barbara Sinigaglia, Antonio Curti, Simonetta Rizzi, Giulia Tolomelli, Roberto M. Lemoli, Francesca Bonifazi, Valeria Giudice, Maria Rosa Motta, Paola Tacchetti, Mario Arpinati, Lucia Pantani, … Katia Mancuso. (2019). The timing of plerixafor addition to G-Csf and chemotherapy affects immunological recovery after autologous stem cell transplant in multiple myeloma.
Chicago
Laura Paris, Francesca Patriarca, Renato Fanin, Monica Galli, Elisa Dan, Andrea Olmo, Beatrice Anna Zannetti, et al. 2019. “The Timing of Plerixafor Addition to G-Csf and Chemotherapy Affects Immunological Recovery after Autologous Stem Cell Transplant in Multiple Myeloma,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b68588ab0c0ceae1e07821073e978145&authtype=sso&custid=ns315887.